[1]
Yeremchenko О. A., “Alternative strategies for investing in corporate R&D (on the example of the global pharmaceutical industry)”, Econ. Sci., vol. 4, no. 4, pp. 309–317, Dec. 2018, doi: 10.22394/2410-132X-2018-4-4-309-317.